Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological update on multiple sclerosis.

R Hohlfeld1, H Wekerle

  • 1Institute for Clinical Neuroimmunology, University of Munich, Klinikum Grosshadern, Munich, Germany. hohlfeld@neuro.mpg.de

Current Opinion in Neurology
|May 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - Commentary.

Multiple sclerosis (Houndmills, Basingstoke, England)·2021
Same author

Nature, nurture, and microbes: The development of multiple sclerosis.

Acta neurologica Scandinavica·2017
Same author

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

Journal of neurology·2016
Same author

[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].

Der Nervenarzt·2016
Same author

[Current aspects of therapy conversion for multiple sclerosis].

Der Nervenarzt·2015
Same author

[Immunotherapies for multiple sclerosis : review and update].

Der Internist·2015
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Recent advances reveal precise analysis of immune responses in multiple sclerosis (MS). Researchers identified new autoantigens and tested targeted immunotherapies for MS treatment.

Area of Science:

  • Immunology
  • Neuroscience
  • Autoimmunity

Background:

  • Multiple sclerosis (MS) involves complex immune reactions targeting the central nervous system.
  • Understanding antigen-specific T cell responses is crucial for developing effective MS therapies.

Purpose of the Study:

  • To review recent literature on antigen-specific immune reactions in multiple sclerosis.
  • To highlight advancements in analytical techniques and therapeutic strategies for MS.

Main Methods:

  • Quantitative analysis of T cell receptor repertoires in the MS brain.
  • Identification of novel candidate autoantigens, including B-cell autoantigens.
  • Utilizing humanized animal models for in vivo functional characterization.
  • Reviewing clinical trial data for selective immunotherapies in MS.

Related Experiment Videos

Main Results:

  • Precise quantitative data on the antigen-receptor repertoire of infiltrating T cells in the MS brain is now available.
  • Novel candidate autoantigens, including B-cell autoantigens, have been identified.
  • Humanized animal models provide insights into the function of human immune molecules in MS pathogenesis.
  • Clinical trials indicate potential benefits of selective immunotherapies for MS patients.

Conclusions:

  • Significant progress has been made in understanding antigen-specific immunity in MS.
  • New tools and models facilitate the study of MS pathogenesis.
  • Selective immunotherapies show promise as a therapeutic approach for MS.